Cargando…

A novel approach in preventing vascular leakage and angiogenesis in wet age-related macular degeneration

Detalles Bibliográficos
Autor principal:	Yamada, Kaori H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2022
Materias:	Perspective
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8820697/ https://www.ncbi.nlm.nih.gov/pubmed/35017431 http://dx.doi.org/10.4103/1673-5374.332147

Ejemplares similares

Imaging of Wet Age-Related Macular Degeneration
por: Kenan, Damer
Publicado: (2016)

Implication of gut microbiome in age-related macular degeneration
por: Luo, Wendy, et al.
Publicado: (2023)

Pegaptanib in the treatment of wet, age-related macular degeneration
por: Vinores, Stanley A
Publicado: (2006)

Bevasiranib for the Treatment of Wet, Age-Related Macular Degeneration
por: Garba, Adinoyi O., et al.
Publicado: (2010)

Future Therapies of Wet Age-Related Macular Degeneration
por: Ishikawa, Makoto, et al.
Publicado: (2015)

VEGFR2 Trafficking by KIF13B Is a Novel Therapeutic Target for Wet Age-Related Macular Degeneration
por: Waters, Stephen B., et al.
Publicado: (2021)

Meteorin Is a Novel Therapeutic Target for Wet Age-Related Macular Degeneration
por: Delaunay, Kimberley, et al.
Publicado: (2021)

Individualized Therapy with Ranibizumab in Wet Age-Related Macular Degeneration
por: García-Layana, Alfredo, et al.
Publicado: (2015)

Wet age related macular degeneration management and follow-up
por: Alexandru, Malciolu Radu, et al.
Publicado: (2016)

Hypertension affects the treatment of wet age‐related macular degeneration
por: Wang, Ting, et al.
Publicado: (2021)

Therapeutic potential of translocator protein ligands for age-related macular degeneration
por: Li, Xing, et al.
Publicado: (2021)

A systems biology approach towards understanding and treating non-neovascular age-related macular degeneration
por: Handa, James T., et al.
Publicado: (2019)

Macular morphology and response to ranibizumab treatment in patients with wet age-related macular degeneration
por: Dervenis, Nikolaos, et al.
Publicado: (2016)

CasRx-mediated RNA targeting prevents choroidal neovascularization in a mouse model of age-related macular degeneration
por: Zhou, Changyang, et al.
Publicado: (2020)

Evaluation of circulating miRNAs in wet age-related macular degeneration
por: Ertekin, Sevda, et al.
Publicado: (2014)

Evaluation of cardiovascular biomarkers in patients with age-related wet macular degeneration
por: Keles, Sadullah, et al.
Publicado: (2014)

Wide-Field Fluorescein Angiography in Wet Age-Related Macular Degeneration
por: Madhusudhan, Savitha, et al.
Publicado: (2014)

Stereotactic radiotherapy for wet age-related macular degeneration: current perspectives
por: Neffendorf, James E, et al.
Publicado: (2015)

Serum Autoantibodies in Patients with Dry and Wet Age-Related Macular Degeneration
por: Korb, Christina A., et al.
Publicado: (2023)

Systemic Dendrimer-Peptide Therapies for Wet Age-Related Macular Degeneration
por: Wu, Tony, et al.
Publicado: (2023)

Age-related macular degeneration: Beyond anti-angiogenesis
por: Kent, David L.
Publicado: (2014)

Macular Hole Formation After Intravitreal Ranibizumab Injection in Wet Age-Related Macular Degeneration
por: Mukherjee, Chandoshi, et al.
Publicado: (2015)

Macular morphology and response to ranibizumab treatment in patients with wet age-related macular degeneration [Corrigendum]
Publicado: (2016)

Effect of Phacoemulsification on Visual Acuity and Macular Morphology in Patients with Wet Age-Related Macular Degeneration
por: Figurska, Małgorzata, et al.
Publicado: (2018)

Comparison of macular pigment optical density in patients with dry and wet age-related macular degeneration
por: Ozyurt, Ayhan, et al.
Publicado: (2017)

Macular Hole Surgery in the Case of Wet Age-Related Macular Degeneration Treated with Intravitreal Aflibercept
por: Nowosielska, Agnieszka
Publicado: (2019)

Nme(2)Cas9‐mediated therapeutic editing in inhibiting angiogenesis after wet age‐related macular degeneration onset
por: Hu, Sihui, et al.
Publicado: (2023)

Preclinical Evaluation of ADVM-022, a Novel Gene Therapy Approach to Treating Wet Age-Related Macular Degeneration
por: Grishanin, Ruslan, et al.
Publicado: (2019)

Patients’ knowledge and perspectives on wet age-related macular degeneration and its treatment
por: Kandula, Sushma, et al.
Publicado: (2010)

Profile of ranibizumab: efficacy and safety for the treatment of wet age-related macular degeneration
por: Chen, Youxin, et al.
Publicado: (2012)

Evaluation of peripheral fundus autofluorescence in eyes with wet age-related macular degeneration
por: Suetsugu, Tetsuyuki, et al.
Publicado: (2016)

Plasma metabolomic study in Chinese patients with wet age-related macular degeneration
por: Luo, Dan, et al.
Publicado: (2017)

Efficacy of ranibizumab combined with photodynamic therapy on wet age-related macular degeneration
por: Chen, Ling, et al.
Publicado: (2020)

Pachychoroid neovasculopathy can mimic wet type age-related macular degeneration
por: Farvardin, Mohsen, et al.
Publicado: (2022)

Inner blood-retina barrier involvement in dry age-related macular degeneration (AMD) pathology
por: Hudson, Natalie, et al.
Publicado: (2020)

Cell-based therapies for age-related macular degeneration: cell replacement versus paracrine effects
por: Peng, Xiaoyan, et al.
Publicado: (2020)

Long-term results after limited macular translocation surgery for wet age-related macular degeneration
por: Oshima, Hisaaki, et al.
Publicado: (2017)

Prevention of age-related macular degeneration
por: Wong, Ian Yat Hin, et al.
Publicado: (2010)

Characterization of SIRT1/DNMTs Functions and LINE-1 Methylation in Patients with Age-Related Macular Degeneration
por: Maugeri, Andrea, et al.
Publicado: (2019)

PPAR-α Ligands as Potential Therapeutic Agents for Wet Age-Related Macular Degeneration
por: del V Cano, Marisol, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_5orj68dbf748969unelo7082h6